Metformin and insulin are considered safe and effective options for managing type 2 diabetes during breastfeeding, with extensive evidence supporting their use and recommendations from NICE and the BNF
Bottom line: CagriSema could become the go-to option for patients who want more than Ozempic alone can offer, especially those struggling with fatty liver disease or stubborn appetite control
It is composed of three amino acids: cysteine, glycine, and glutamic acid
But there may not be ideal doses of MSM for any condition, as researchers are still studying this compound
In findings from a phase 2a trial that were presented at the American Diabetes Association Scientific Sessions and simultaneously published in The Lancet , 71% of adults receiving coadministered cagrilintide and semaglutide 2.4 mg, dubbed CagriSema (Novo Nordisk), lost at least 10% of their body weight, and 89% of adults achieved an HbA1c of less than 7% with the combination therapy